IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24,080 | -9.0% | 3,941 | -4.9% | 0.00% | -100.0% |
| Q4 2022 | $26,467 | -93.6% | 4,142 | -90.4% | 0.00% | -88.9% |
| Q3 2022 | $414,000 | -21.0% | 43,168 | -9.0% | 0.01% | -10.0% |
| Q2 2022 | $524,000 | -45.1% | 47,439 | -17.2% | 0.01% | -33.3% |
| Q1 2022 | $954,000 | -46.4% | 57,322 | -38.5% | 0.02% | -40.0% |
| Q4 2021 | $1,779,000 | -23.9% | 93,167 | -1.7% | 0.02% | -30.6% |
| Q3 2021 | $2,337,000 | -3.8% | 94,778 | +1.5% | 0.04% | 0.0% |
| Q2 2021 | $2,430,000 | -0.3% | 93,391 | +21.4% | 0.04% | -5.3% |
| Q1 2021 | $2,437,000 | +26.3% | 76,959 | +85.2% | 0.04% | +18.8% |
| Q4 2020 | $1,929,000 | +977.7% | 41,563 | +665.0% | 0.03% | +966.7% |
| Q3 2020 | $179,000 | +123.8% | 5,433 | +86.3% | 0.00% | +50.0% |
| Q2 2020 | $80,000 | – | 2,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |